BioNTech stock was rising after the drugmaker reported better-than-expected results early Monday. The company’s ...

BioNTech (BNTX) stock gains as the company surpasses Q2 2025 forecasts with 103% YoY revenue growth, thanks mainly to Pfizer ...

FRANKFURT (Reuters) -German biotech firm BioNTech on Monday said that second-quarter revenues more than doubled to 261 ...

Vaccines help protect students, staff, family and the community from serious vaccine-preventable diseases,” a local public ...

Continued execution of BioNTech’s oncology strategy with focus on two pan-tumor programs including two announced transactions: mRNA-based cancer immunotherapy candidates and BNT327, a bispecific ...

Subtle differences in molecular structure can have a major impact on the performance of mRNA-based drugs. The findings open ...

Should you get vaccinated? Will your insurer pay for it? And will you still be able to find a vaccine? KFF Health News tries to sort out where things stand.

Summer heat, outdoor fun … and cold and flu symptoms? The three may not go together in many people’s minds: partly owing to ...

The company reported a net loss of $825 million for the quarter. Additionally, Moderna announced a $300 million reduction at the high end of their 2025 projected revenue range due to a timing shift of ...

As the country continues to deal with the fallout of the infamous Jeffery Epstein files, The Root is taking a closer look at some of the most polarizing conspiracy theories in American history.

In an earnings call on July 29th, in which the company reported a 13% increase in half-year profits, he said about Britain ...

The pharmaceutical industry continues to evolve rapidly, driven by innovation, global health challenges, and technological ...